Bucindolol: A Pharmacogenomic Perspective on its Use in Chronic Heart Failure

Bucindolol: A Pharmacogenomic Perspective on its Use in Chronic Heart Failure

Show other versions (1)

Bucindolol is a non-selective β-adrenergic receptor blocker with α-1 blocker properties and mild intrinsic sympatholytic activity. The Beta-Blocker Evaluation of Survival Trial (BEST), which is the largest clinical trial of bucindolol in patients with heart failure, was terminated prematurely and fa...

Full description

Bibliographic Details
Main Authors:	Neil A. Smart, Nigel Kwok, David J. Holland, Rohan Jayasighe, Francesco Giallauria
Format:	Article
Language:	English
Published:	SAGE Publishing 2011-01-01
Series:	Clinical Medicine Insights: Cardiology
Online Access:	https://doi.org/10.4137/CMC.S4309

Similar Items

Bucindolol: A Pharmacogenomic Perspective on Its Use in Chronic Heart Failure
by: Neil A. Smart, et al.
Published: (2011-06-01)

A personalized BEST: characterization of latent clinical classes of nonischemic heart failure that predict outcomes and response to bucindolol.
by: David P Kao, et al.
Published: (2012-01-01)

Exercise training modalities in chronic heart failure: does high intensity aerobic interval training make the difference?
by: Francesco Giallauria, et al.
Published: (2016-10-01)

Ex Ante Economic Evaluations of Arg389 Genetic Testing and Bucindolol Treatment Decisions in Heart Failure Stage III/IV
by: Alsaid, Nimer, et al.
Published: (2017)

Exercise training in heart failure patients with preserved ejection fraction: a systematic review and meta-analysis
by: Erick Chan, et al.
Published: (2016-10-01)

Tailoring therapy for heart failure: the pharmacogenomics of adrenergic receptor signaling
by: Femminella GD, et al.
Published: (2014-09-01)

Combinatorial pharmacogenetic interactions of bucindolol and β1, α2C adrenergic receptor polymorphisms.
by: Christopher M O'Connor, et al.
Published: (2012-01-01)

Testosterone treatment in chronic heart failure. Review of literature and future perspectives
by: Roberta D'Assante, et al.
Published: (2018-09-01)

Exercise training in patients with chronic heart failure: A new challenge for Cardiac Rehabilitation Community
by: Francesco Giallauria, et al.
Published: (2018-09-01)

Bucindolol Modulates Cardiac Remodeling by Attenuating Oxidative Stress in H9c2 Cardiac Cells Exposed to Norepinephrine
by: Bruna Gazzi de Lima-Seolin, et al.
Published: (2019-01-01)

Pharmacogenomics In Pharmacy Practice: Current Perspectives
by: Elewa H, et al.
Published: (2019-11-01)

Clopidogrel: A Pharmacogenomic Perspective on its Use in Coronary Artery Disease
by: Chris Terpening
Published: (2010-12-01)

Clopidogrel: A Pharmacogenomic Perspective on its Use in Coronary Artery Disease
by: Chris Terpening
Published: (2010-01-01)

The Perspective of Application of Artificial Intelligence in Pharmacogenomics and Pharmacoproteomics
by: Evans Chimayi Chirambo, et al.
Published: (2018)

Adoption of Pharmacogenomic Testing: A Marketing Perspective
by: Margarita-Ioanna Koufaki, et al.
Published: (2021-09-01)

Chronic heart failure: New challenges and new perspectives
by: S N Tereshchenko, et al.
Published: (2017-09-01)

Deciphering next-generation pharmacogenomics: an information technology perspective
by: George Potamias, et al.
Published: (2014-01-01)

Developments in renal pharmacogenomics and applications in chronic kidney disease
by: Padullés A, et al.
Published: (2014-08-01)

Diagnosis of sleep-disordered breathing in chronic heart failure
by: Ward, Neil Robert
Published: (2011)

Exercise Training for Heart Failure Patients with and without Systolic Dysfunction: An Evidence-Based Analysis of How Patients Benefit
by: Neil Smart
Published: (2011-01-01)

How Can Malnutrition Affect Autophagy in Chronic Heart Failure? Focus and Perspectives
by: Giovanni Corsetti, et al.
Published: (2021-03-01)

Cancer pharmacogenomics, challenges in implementation, and patient-focused perspectives
by: Patel JN
Published: (2016-07-01)

Pharmacogenomics of Antibiotics
by: Gabriele Stocco, et al.
Published: (2020-08-01)

Pharmacogenomics in the newborn
by: Mirta Corsello, et al.
Published: (2013-08-01)

Pharmacogenomic Biomarkers
by: Sandra C. Kirkwood, et al.
Published: (2002-01-01)

Anti remodeling therapy: new strategies and future perspective in post-ischemic heart failure. Part II
by: Andrea Salzano, et al.
Published: (2015-11-01)

Anti remodeling therapy: new strategies and future perspective in post-ischemic heart failure: Part I
by: Domenico Sirico, et al.
Published: (2015-11-01)

A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics.
by: Clint Mizzi, et al.
Published: (2016-01-01)

Pharmacogenomics of Cardiovascular Pharmacology: Pharmacogenomic Network of Cardiovascular Disease Models
by: Toshio Tanaka, et al.
Published: (2008-01-01)

Efeitos do beta-bloqueador bucindolol na modulação do remodelamento do ventrículo direito em modelo de hipertensão pulmonar induzida por monocrotalina
by: Seolin, Bruna Gazzi de Lima
Published: (2016)

Efeitos do beta-bloqueador bucindolol na modulação do remodelamento do ventrículo direito em modelo de hipertensão pulmonar induzida por monocrotalina
by: Seolin, Bruna Gazzi de Lima
Published: (2016)

Efeitos do beta-bloqueador bucindolol na modulação do remodelamento do ventrículo direito em modelo de hipertensão pulmonar induzida por monocrotalina
by: Seolin, Bruna Gazzi de Lima
Published: (2016)

Studies of immune function in chronic heart failure, inflammation in the progression of chronic heart failure
by: Von Lanzenauer, Stephan Haehling
Published: (2010)

Correction: A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics.
by: Clint Mizzi, et al.
Published: (2017-01-01)

6th Golden Helix Pharmacogenomics Day: pharmacogenomics and individualized therapy
by: Stojiljkovic Maja, et al.
Published: (2012-09-01)

NEURO-HUMORAL DISBALANCE IN CHRONIC HEART FAILURE: CLASSIC AND MODERN PERSPECTIVES
by: A. G. Obrezan, et al.
Published: (2017-10-01)

Pharmacogenomics From Basic Research to Clinical Implementation
Published: (2022)

CPAP in chronic heart failure
by: F. Lari, et al.
Published: (2013-05-01)

Ivabradine in Chronic Heart Failure
by: Hadeer Eid, et al.
Published: (2020-06-01)

Anaemia and chronic heart failure
by: T. A. Kazantseva, et al.
Published: (2010-08-01)

Cannot write session to /tmp/vufind_sessions/sess_719vk018df6d6ptu4kkeh89q3l